This edition includes information on the ACCESS model application period extension, annual wellness visits, clinical laboratory fee schedule, and more.
View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.
Please be aware the transition to new site visit contractors is causing delays in receiving results. Continue reading to be aware of this temporary situation.
Get bragging rights around the office by placing your name alongside others on our honorary Medicare Navigator Notable Wall by earning any of our digital badges.